

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.71788428 |
| 2 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.57519801 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.51358590 |
| 4 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.49676320 |
| 5 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.42790919 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.36768265 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.36768265 |
| 8 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.26699775 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.07106209 |
| 10 | negative T cell selection (GO:0043383) | 4.02584631 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.89700532 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.89700532 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.89700532 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.89700532 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.89700532 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.89700532 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.88602052 |
| 18 | response to interleukin-15 (GO:0070672) | 3.88517446 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.87159243 |
| 20 | positive thymic T cell selection (GO:0045059) | 3.86435981 |
| 21 | positive regulation of interleukin-2 production (GO:0032743) | 3.85905596 |
| 22 | positive T cell selection (GO:0043368) | 3.84593898 |
| 23 | positive regulation of T cell cytokine production (GO:0002726) | 3.81438882 |
| 24 | regulation of vitamin metabolic process (GO:0030656) | 3.76517976 |
| 25 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.73095212 |
| 26 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.70044442 |
| 27 | myeloid dendritic cell differentiation (GO:0043011) | 3.67579419 |
| 28 | positive regulation of humoral immune response (GO:0002922) | 3.63529936 |
| 29 | activated T cell proliferation (GO:0050798) | 3.60019059 |
| 30 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.56847242 |
| 31 | T-helper cell differentiation (GO:0042093) | 3.56847242 |
| 32 | cellular response to nicotine (GO:0071316) | 3.56158263 |
| 33 | interferon-gamma production (GO:0032609) | 3.53560300 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.51448232 |
| 35 | leukocyte aggregation (GO:0070486) | 3.51229038 |
| 36 | regulation of immunoglobulin secretion (GO:0051023) | 3.50477131 |
| 37 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.40811660 |
| 38 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.37295756 |
| 39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.36728993 |
| 40 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.36348027 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.34520444 |
| 42 | response to peptidoglycan (GO:0032494) | 3.31527535 |
| 43 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.31431638 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 3.31241284 |
| 45 | regulation of isotype switching (GO:0045191) | 3.30536526 |
| 46 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.30403321 |
| 47 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.26860464 |
| 48 | T cell selection (GO:0045058) | 3.25535116 |
| 49 | defense response to protozoan (GO:0042832) | 3.25499645 |
| 50 | positive regulation of interleukin-17 production (GO:0032740) | 3.23303064 |
| 51 | positive regulation of B cell mediated immunity (GO:0002714) | 3.21447089 |
| 52 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.21447089 |
| 53 | regulation of T-helper cell differentiation (GO:0045622) | 3.21288956 |
| 54 | myeloid dendritic cell activation (GO:0001773) | 3.18812003 |
| 55 | thymic T cell selection (GO:0045061) | 3.16103511 |
| 56 | T cell migration (GO:0072678) | 3.15989047 |
| 57 | positive regulation of isotype switching (GO:0045830) | 3.15460007 |
| 58 | regulation of interleukin-2 production (GO:0032663) | 3.13954808 |
| 59 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09219803 |
| 60 | mast cell activation (GO:0045576) | 3.07235486 |
| 61 | regulation of chronic inflammatory response (GO:0002676) | 3.07078594 |
| 62 | response to protozoan (GO:0001562) | 3.05319777 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05319141 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04742852 |
| 65 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.03747032 |
| 66 | tolerance induction (GO:0002507) | 3.03311722 |
| 67 | T cell differentiation involved in immune response (GO:0002292) | 3.02050003 |
| 68 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.02050003 |
| 69 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.02050003 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99911594 |
| 71 | germinal center formation (GO:0002467) | 2.97306431 |
| 72 | regulation of immunoglobulin production (GO:0002637) | 2.96579344 |
| 73 | positive regulation of B cell proliferation (GO:0030890) | 2.96041453 |
| 74 | regulation of chemokine biosynthetic process (GO:0045073) | 2.95273377 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.95216716 |
| 76 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.94456147 |
| 77 | positive regulation of interleukin-10 production (GO:0032733) | 2.94249474 |
| 78 | response to muramyl dipeptide (GO:0032495) | 2.94181266 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 2.92749019 |
| 80 | regulation of germinal center formation (GO:0002634) | 2.89572349 |
| 81 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87133911 |
| 82 | positive regulation of heat generation (GO:0031652) | 2.84744228 |
| 83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.84440760 |
| 84 | T cell lineage commitment (GO:0002360) | 2.83592952 |
| 85 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.82709352 |
| 86 | negative regulation of monooxygenase activity (GO:0032769) | 2.82154720 |
| 87 | regulation of interleukin-17 production (GO:0032660) | 2.81142196 |
| 88 | macrophage activation involved in immune response (GO:0002281) | 2.81006022 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80569626 |
| 90 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.80460849 |
| 91 | regulation of T cell cytokine production (GO:0002724) | 2.80113487 |
| 92 | T-helper 1 type immune response (GO:0042088) | 2.79894464 |
| 93 | T cell receptor signaling pathway (GO:0050852) | 2.78601837 |
| 94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78250094 |
| 95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.76876594 |
| 96 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.76642740 |
| 97 | positive regulation of immunoglobulin production (GO:0002639) | 2.76056445 |
| 98 | positive regulation of DNA recombination (GO:0045911) | 2.76039595 |
| 99 | modulation by symbiont of host cellular process (GO:0044068) | 2.75079337 |
| 100 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.74750229 |
| 101 | activation of MAPKKK activity (GO:0000185) | 2.74385837 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73234654 |
| 103 | positive regulation of B cell activation (GO:0050871) | 2.72998693 |
| 104 | regulation of interleukin-12 production (GO:0032655) | 2.72355121 |
| 105 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70948161 |
| 106 | positive regulation of defense response to virus by host (GO:0002230) | 2.70162519 |
| 107 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.70035692 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.70035692 |
| 109 | B cell homeostasis (GO:0001782) | 2.69135592 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68901294 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.68671616 |
| 112 | response to host immune response (GO:0052572) | 2.68671616 |
| 113 | T cell proliferation (GO:0042098) | 2.67363542 |
| 114 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.65767720 |
| 115 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.65446301 |
| 116 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.64343063 |
| 117 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.64343063 |
| 118 | immunoglobulin mediated immune response (GO:0016064) | 2.64164027 |
| 119 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.63894119 |
| 120 | T cell costimulation (GO:0031295) | 2.63585173 |
| 121 | T cell activation involved in immune response (GO:0002286) | 2.62917750 |
| 122 | mature B cell differentiation (GO:0002335) | 2.62738960 |
| 123 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62597265 |
| 124 | regulation of memory T cell differentiation (GO:0043380) | 2.62397126 |
| 125 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.62208834 |
| 126 | regulation of fever generation (GO:0031620) | 2.61178941 |
| 127 | regulation of T cell tolerance induction (GO:0002664) | 2.59877538 |
| 128 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59628297 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.59417648 |
| 130 | lymphocyte costimulation (GO:0031294) | 2.58629800 |
| 131 | response to type I interferon (GO:0034340) | 2.56988225 |
| 132 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.56138567 |
| 133 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.56138567 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.55914570 |
| 135 | cellular response to type I interferon (GO:0071357) | 2.55914570 |
| 136 | myeloid cell activation involved in immune response (GO:0002275) | 2.55492669 |
| 137 | positive regulation of interleukin-12 production (GO:0032735) | 2.55458515 |
| 138 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.54627021 |
| 139 | regulation of B cell mediated immunity (GO:0002712) | 2.54205572 |
| 140 | positive regulation of astrocyte differentiation (GO:0048711) | 2.52518858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.41319514 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.78951670 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.64208143 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.50708877 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.01295018 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99988476 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.97344146 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.86682809 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74816843 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54035670 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41979412 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.41914193 |
| 13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.41736045 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29940893 |
| 15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.25718184 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.24706526 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.22573593 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21385981 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06494931 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99684941 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97384804 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93840436 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93705594 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88429954 |
| 25 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85367461 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77108362 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67938866 |
| 28 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66699349 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.60752636 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.60371516 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57825033 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52855990 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50287545 |
| 34 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49612795 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48850464 |
| 36 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48323979 |
| 37 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46885931 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46664607 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.45834024 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.45785241 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44519337 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43825879 |
| 43 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41002145 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37985849 |
| 45 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.36579562 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35909985 |
| 47 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.35499928 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34636179 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32379987 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.31453388 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.28864115 |
| 52 | * MAF_26560356_Chip-Seq_TH1_Human | 1.28136791 |
| 53 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26564887 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25808996 |
| 55 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25433361 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24240236 |
| 57 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22618887 |
| 58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21777818 |
| 59 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.21729429 |
| 60 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.21270974 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20323245 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20106180 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19138351 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18808450 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18003140 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17748329 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16314184 |
| 68 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14252929 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13565434 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13469374 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12864926 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12633781 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12407552 |
| 74 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12324194 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09708878 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08414785 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08087830 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07672553 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06035739 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05991794 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04032700 |
| 82 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03476824 |
| 83 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02993624 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02916320 |
| 85 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02636587 |
| 86 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.02542894 |
| 87 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.02542894 |
| 88 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02117993 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01774471 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01744764 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00447106 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99945301 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98709213 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98221164 |
| 95 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98168648 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98021093 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94256270 |
| 98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93774397 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93086316 |
| 100 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92829595 |
| 101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91189273 |
| 102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91030613 |
| 103 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90818309 |
| 104 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90542897 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90457303 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90192732 |
| 107 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89628278 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89371107 |
| 109 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.89286689 |
| 110 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88751482 |
| 111 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87904104 |
| 112 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86760268 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86750815 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85048545 |
| 115 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84146018 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82826472 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82422806 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82240515 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81828993 |
| 120 | * MAF_26560356_Chip-Seq_TH2_Human | 0.81784759 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81758369 |
| 122 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81716604 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81699208 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81656260 |
| 125 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.81492145 |
| 126 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81015904 |
| 127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80114594 |
| 128 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.79912735 |
| 129 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.79627707 |
| 130 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79298720 |
| 131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79185009 |
| 132 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78766356 |
| 133 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76067094 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75812026 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71310525 |
| 136 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70868661 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70739305 |
| 138 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70485416 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70041940 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64522357 |
| 141 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.64507224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.14771984 |
| 2 | MP0004510_myositis | 3.38451278 |
| 3 | MP0003436_decreased_susceptibility_to | 3.21030467 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.14952420 |
| 5 | MP0005387_immune_system_phenotype | 3.09917053 |
| 6 | MP0001790_abnormal_immune_system | 3.09917053 |
| 7 | MP0005671_abnormal_response_to | 2.86966752 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.81478173 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.71721156 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.67754535 |
| 11 | MP0000685_abnormal_immune_system | 2.66082765 |
| 12 | MP0001800_abnormal_humoral_immune | 2.54364967 |
| 13 | MP0009785_altered_susceptibility_to | 2.46936060 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.45641841 |
| 15 | MP0006082_CNS_inflammation | 2.38345332 |
| 16 | * MP0002723_abnormal_immune_serum | 2.29481850 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.25102891 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.20143440 |
| 19 | MP0003724_increased_susceptibility_to | 2.19377886 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.19311005 |
| 21 | MP0003866_abnormal_defecation | 2.15408157 |
| 22 | MP0005025_abnormal_response_to | 2.12604578 |
| 23 | MP0002405_respiratory_system_inflammati | 2.07167753 |
| 24 | MP0002419_abnormal_innate_immunity | 2.01863826 |
| 25 | MP0009278_abnormal_bone_marrow | 2.01620000 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.01461000 |
| 27 | MP0001819_abnormal_immune_cell | 2.00597750 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.95932047 |
| 29 | MP0003880_abnormal_central_pattern | 1.86897100 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.78979887 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.76567890 |
| 32 | MP0002006_tumorigenesis | 1.70043750 |
| 33 | * MP0002398_abnormal_bone_marrow | 1.69261454 |
| 34 | MP0002933_joint_inflammation | 1.66250631 |
| 35 | MP0000604_amyloidosis | 1.63171931 |
| 36 | MP0005310_abnormal_salivary_gland | 1.59983774 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.55760148 |
| 38 | * MP0000716_abnormal_immune_system | 1.55156465 |
| 39 | MP0009745_abnormal_behavioral_response | 1.51006421 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.49434957 |
| 41 | MP0002064_seizures | 1.48589419 |
| 42 | MP0001853_heart_inflammation | 1.48194119 |
| 43 | MP0009840_abnormal_foam_cell | 1.45684238 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.45573581 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.44073327 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.43191076 |
| 47 | MP0004381_abnormal_hair_follicle | 1.41657116 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.41082255 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.39697448 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.39483355 |
| 51 | MP0004947_skin_inflammation | 1.35822192 |
| 52 | MP0004742_abnormal_vestibular_system | 1.35295918 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.33948918 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.33673514 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.32151941 |
| 56 | MP0002254_reproductive_system_inflammat | 1.28382517 |
| 57 | MP0004270_analgesia | 1.28343224 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.28229681 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.27908108 |
| 60 | MP0001873_stomach_inflammation | 1.26797050 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.23370335 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.23370335 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.22769379 |
| 64 | MP0009046_muscle_twitch | 1.22282305 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.22156101 |
| 66 | MP0008569_lethality_at_weaning | 1.20470409 |
| 67 | MP0001851_eye_inflammation | 1.20086928 |
| 68 | MP0003075_altered_response_to | 1.19697614 |
| 69 | MP0002722_abnormal_immune_system | 1.18035360 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.15149551 |
| 71 | MP0002572_abnormal_emotion/affect_behav | 1.14407248 |
| 72 | MP0000343_altered_response_to | 1.12621381 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.11442220 |
| 74 | MP0002736_abnormal_nociception_after | 1.10614345 |
| 75 | * MP0002429_abnormal_blood_cell | 1.10365574 |
| 76 | * MP0002998_abnormal_bone_remodeling | 1.10344228 |
| 77 | MP0005451_abnormal_body_composition | 1.09602287 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.09038513 |
| 79 | MP0001486_abnormal_startle_reflex | 1.08519439 |
| 80 | MP0002272_abnormal_nervous_system | 1.06166525 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.05908917 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.05764842 |
| 83 | MP0000858_altered_metastatic_potential | 1.00792832 |
| 84 | MP0003329_amyloid_beta_deposits | 1.00471416 |
| 85 | MP0001440_abnormal_grooming_behavior | 0.99572444 |
| 86 | MP0003045_fibrosis | 0.95924910 |
| 87 | MP0000920_abnormal_myelination | 0.95910672 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.94959152 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.91039340 |
| 90 | MP0003633_abnormal_nervous_system | 0.90552037 |
| 91 | MP0003091_abnormal_cell_migration | 0.90060651 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.89612255 |
| 93 | MP0004858_abnormal_nervous_system | 0.89508626 |
| 94 | MP0001970_abnormal_pain_threshold | 0.88716638 |
| 95 | MP0003448_altered_tumor_morphology | 0.88313129 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.88208440 |
| 97 | MP0003828_pulmonary_edema | 0.86648605 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.86549949 |
| 99 | MP0005166_decreased_susceptibility_to | 0.86207342 |
| 100 | MP0003690_abnormal_glial_cell | 0.86163513 |
| 101 | MP0002734_abnormal_mechanical_nocicepti | 0.86097841 |
| 102 | MP0002733_abnormal_thermal_nociception | 0.85565306 |
| 103 | MP0009764_decreased_sensitivity_to | 0.84233844 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.83802224 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.83115487 |
| 106 | MP0001502_abnormal_circadian_rhythm | 0.80277289 |
| 107 | MP0005670_abnormal_white_adipose | 0.79227250 |
| 108 | MP0003195_calcinosis | 0.77593192 |
| 109 | MP0002693_abnormal_pancreas_physiology | 0.73985064 |
| 110 | MP0008057_abnormal_DNA_replication | 0.73625747 |
| 111 | MP0008469_abnormal_protein_level | 0.73544170 |
| 112 | MP0001663_abnormal_digestive_system | 0.72276694 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.71960266 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.70334565 |
| 115 | MP0002184_abnormal_innervation | 0.69969628 |
| 116 | MP0004811_abnormal_neuron_physiology | 0.69449251 |
| 117 | MP0005647_abnormal_sex_gland | 0.67726392 |
| 118 | MP0001881_abnormal_mammary_gland | 0.66301056 |
| 119 | MP0000371_diluted_coat_color | 0.65917616 |
| 120 | MP0005535_abnormal_body_temperature | 0.64946560 |
| 121 | MP0009763_increased_sensitivity_to | 0.63683903 |
| 122 | MP0005390_skeleton_phenotype | 0.63517578 |
| 123 | MP0002909_abnormal_adrenal_gland | 0.63327431 |
| 124 | MP0003631_nervous_system_phenotype | 0.63281257 |
| 125 | MP0005164_abnormal_response_to | 0.61065772 |
| 126 | MP0001348_abnormal_lacrimal_gland | 0.59413869 |
| 127 | MP0003950_abnormal_plasma_membrane | 0.59179105 |
| 128 | MP0002132_abnormal_respiratory_system | 0.59142547 |
| 129 | MP0003646_muscle_fatigue | 0.58862857 |
| 130 | MP0009115_abnormal_fat_cell | 0.54869042 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.54633917 |
| 132 | MP0008004_abnormal_stomach_pH | 0.54569176 |
| 133 | MP0004883_abnormal_blood_vessel | 0.54191715 |
| 134 | MP0003879_abnormal_hair_cell | 0.54122812 |
| 135 | MP0000249_abnormal_blood_vessel | 0.53961390 |
| 136 | MP0005075_abnormal_melanosome_morpholog | 0.53642397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.82177321 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.75517590 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.76162907 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.76162907 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.76162907 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.47163192 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.01797569 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 3.99002760 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.89081379 |
| 10 | Recurrent cutaneous fungal infections (HP:0011370) | 3.88283296 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.88283296 |
| 12 | T lymphocytopenia (HP:0005403) | 3.78227509 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77988120 |
| 14 | Recurrent viral infections (HP:0004429) | 3.71973001 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.70496637 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.52121774 |
| 17 | Focal motor seizures (HP:0011153) | 3.40932149 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.40484529 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 3.16244550 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.06444817 |
| 21 | Diplopia (HP:0000651) | 2.98149018 |
| 22 | Abnormality of binocular vision (HP:0011514) | 2.98149018 |
| 23 | Mutism (HP:0002300) | 2.94391232 |
| 24 | Chronic diarrhea (HP:0002028) | 2.91088763 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.90564378 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.90564378 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.90564378 |
| 28 | Recurrent skin infections (HP:0001581) | 2.85199606 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81097656 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 2.77285381 |
| 31 | Increased IgM level (HP:0003496) | 2.75725094 |
| 32 | Vasculitis (HP:0002633) | 2.75137131 |
| 33 | Obstructive sleep apnea (HP:0002870) | 2.73566232 |
| 34 | Pulmonary infiltrates (HP:0002113) | 2.72978672 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70809980 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.70809980 |
| 37 | Loss of speech (HP:0002371) | 2.65468121 |
| 38 | Focal seizures (HP:0007359) | 2.61961109 |
| 39 | Abnormality of T cells (HP:0002843) | 2.60215624 |
| 40 | Gingivitis (HP:0000230) | 2.50374450 |
| 41 | Obstructive lung disease (HP:0006536) | 2.47347938 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47347938 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.46990757 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.46918201 |
| 45 | Optic neuritis (HP:0100653) | 2.46918201 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.45496638 |
| 47 | Abnormality of the columella (HP:0009929) | 2.37741496 |
| 48 | Persistence of primary teeth (HP:0006335) | 2.37382870 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.33552850 |
| 50 | Basal ganglia calcification (HP:0002135) | 2.33408430 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.32406975 |
| 52 | B lymphocytopenia (HP:0010976) | 2.31845898 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.31845898 |
| 54 | Chronic otitis media (HP:0000389) | 2.31137792 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.29552221 |
| 56 | Fatigue (HP:0012378) | 2.28082090 |
| 57 | Restrictive lung disease (HP:0002091) | 2.28033035 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27101809 |
| 59 | Myositis (HP:0100614) | 2.25915584 |
| 60 | Clumsiness (HP:0002312) | 2.24973604 |
| 61 | Visual hallucinations (HP:0002367) | 2.24864140 |
| 62 | Spondylolisthesis (HP:0003302) | 2.23259541 |
| 63 | Encephalitis (HP:0002383) | 2.21023871 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.20202009 |
| 65 | Arterial thrombosis (HP:0004420) | 2.19661291 |
| 66 | Abnormality of the fingertips (HP:0001211) | 2.19079976 |
| 67 | IgA deficiency (HP:0002720) | 2.18782243 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 2.18350156 |
| 69 | Increased density of long bones (HP:0006392) | 2.17047255 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.15933361 |
| 71 | Cheilitis (HP:0100825) | 2.15651383 |
| 72 | Emphysema (HP:0002097) | 2.15597750 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.15253749 |
| 74 | Urethral obstruction (HP:0000796) | 2.14933907 |
| 75 | Truncal ataxia (HP:0002078) | 2.14403898 |
| 76 | Cerebral inclusion bodies (HP:0100314) | 2.14205081 |
| 77 | Febrile seizures (HP:0002373) | 2.14082130 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.14045289 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13860360 |
| 80 | Pustule (HP:0200039) | 2.12621474 |
| 81 | Premature loss of primary teeth (HP:0006323) | 2.12297689 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.12056057 |
| 83 | Supranuclear gaze palsy (HP:0000605) | 2.11266369 |
| 84 | Nuclear cataract (HP:0100018) | 2.10651808 |
| 85 | Hemoptysis (HP:0002105) | 2.10019377 |
| 86 | Colitis (HP:0002583) | 2.09275146 |
| 87 | Epileptic encephalopathy (HP:0200134) | 2.08203955 |
| 88 | Short 1st metacarpal (HP:0010034) | 2.07495573 |
| 89 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.07495573 |
| 90 | Periodontitis (HP:0000704) | 2.06899881 |
| 91 | Meningitis (HP:0001287) | 2.06243038 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.05958239 |
| 93 | Inflammation of the large intestine (HP:0002037) | 2.05625096 |
| 94 | Leukocytosis (HP:0001974) | 2.04254366 |
| 95 | IgG deficiency (HP:0004315) | 2.03787013 |
| 96 | Chest pain (HP:0100749) | 2.01638081 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.01630142 |
| 98 | Increased serum ferritin (HP:0003281) | 2.00720352 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.00328460 |
| 100 | Joint swelling (HP:0001386) | 1.99935655 |
| 101 | Orchitis (HP:0100796) | 1.99760479 |
| 102 | Progressive inability to walk (HP:0002505) | 1.99080359 |
| 103 | Recurrent bronchitis (HP:0002837) | 1.99012920 |
| 104 | Nasal polyposis (HP:0100582) | 1.99007091 |
| 105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98481331 |
| 106 | Hematochezia (HP:0002573) | 1.98468147 |
| 107 | Increased IgE level (HP:0003212) | 1.97779087 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 1.97737327 |
| 109 | Increased cerebral lipofuscin (HP:0011813) | 1.96528399 |
| 110 | Myocardial infarction (HP:0001658) | 1.94866394 |
| 111 | Impaired smooth pursuit (HP:0007772) | 1.94229777 |
| 112 | Absence seizures (HP:0002121) | 1.94120456 |
| 113 | Inappropriate behavior (HP:0000719) | 1.93287305 |
| 114 | Spontaneous hematomas (HP:0007420) | 1.93187582 |
| 115 | Apathy (HP:0000741) | 1.92631411 |
| 116 | Agammaglobulinemia (HP:0004432) | 1.92592592 |
| 117 | Parakeratosis (HP:0001036) | 1.92315847 |
| 118 | Dysmetria (HP:0001310) | 1.92270334 |
| 119 | Progressive cerebellar ataxia (HP:0002073) | 1.91240574 |
| 120 | Abnormality of T cell physiology (HP:0011840) | 1.90499404 |
| 121 | Cellulitis (HP:0100658) | 1.88770563 |
| 122 | Abnormal hair whorl (HP:0010721) | 1.88170421 |
| 123 | Axonal loss (HP:0003447) | 1.87844414 |
| 124 | Lymphopenia (HP:0001888) | 1.87550855 |
| 125 | Acrocyanosis (HP:0001063) | 1.84645265 |
| 126 | Slow saccadic eye movements (HP:0000514) | 1.81954721 |
| 127 | Arthralgia (HP:0002829) | 1.81364671 |
| 128 | Peripheral hypomyelination (HP:0007182) | 1.80356870 |
| 129 | Porencephaly (HP:0002132) | 1.80230048 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80117020 |
| 131 | Eosinophilia (HP:0001880) | 1.79973894 |
| 132 | Thyroiditis (HP:0100646) | 1.79729817 |
| 133 | Dialeptic seizures (HP:0011146) | 1.78147826 |
| 134 | Genetic anticipation (HP:0003743) | 1.77902388 |
| 135 | Oligodontia (HP:0000677) | 1.75307362 |
| 136 | Absent frontal sinuses (HP:0002688) | 1.74434185 |
| 137 | Disinhibition (HP:0000734) | 1.74018525 |
| 138 | Myokymia (HP:0002411) | 1.73957595 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73138359 |
| 140 | Macroorchidism (HP:0000053) | 1.73006996 |
| 141 | Abnormality of eosinophils (HP:0001879) | 1.72717255 |
| 142 | Stereotypic behavior (HP:0000733) | 1.72700230 |
| 143 | Neurofibrillary tangles (HP:0002185) | 1.72482940 |
| 144 | Diminished motivation (HP:0000745) | 1.71553085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.25986211 |
| 2 | TXK | 3.99525490 |
| 3 | RIPK4 | 3.79357363 |
| 4 | MAP3K14 | 3.45021613 |
| 5 | JAK3 | 3.35614540 |
| 6 | ZAP70 | 2.60069991 |
| 7 | SIK2 | 2.25488340 |
| 8 | MAP3K13 | 2.13883423 |
| 9 | TAOK1 | 2.00626178 |
| 10 | GRK7 | 1.95841530 |
| 11 | CDC42BPA | 1.88713030 |
| 12 | FES | 1.74068521 |
| 13 | ERN1 | 1.71390351 |
| 14 | IKBKB | 1.69711307 |
| 15 | ADRBK2 | 1.60033437 |
| 16 | TYK2 | 1.59531940 |
| 17 | IKBKE | 1.59219573 |
| 18 | CHUK | 1.57901672 |
| 19 | NTRK3 | 1.57885735 |
| 20 | NTRK2 | 1.56534053 |
| 21 | NME2 | 1.54107749 |
| 22 | SYK | 1.50519968 |
| 23 | HCK | 1.48499998 |
| 24 | JAK1 | 1.48356523 |
| 25 | BLK | 1.47115766 |
| 26 | SIK3 | 1.44196776 |
| 27 | TBK1 | 1.41543500 |
| 28 | LCK | 1.37811225 |
| 29 | MATK | 1.36986717 |
| 30 | MAP3K7 | 1.35308185 |
| 31 | CAMK1G | 1.34877980 |
| 32 | DDR2 | 1.32025855 |
| 33 | EPHB1 | 1.30270472 |
| 34 | DAPK2 | 1.26747999 |
| 35 | PRKCH | 1.26553054 |
| 36 | CSK | 1.25925284 |
| 37 | EPHA4 | 1.22801875 |
| 38 | IRAK3 | 1.20839926 |
| 39 | ITK | 1.19257954 |
| 40 | MAP3K9 | 1.18671391 |
| 41 | CDK12 | 1.17600619 |
| 42 | TAOK2 | 1.17103373 |
| 43 | TGFBR2 | 1.16832381 |
| 44 | TAOK3 | 1.15307532 |
| 45 | MAPK7 | 1.08085545 |
| 46 | BMPR2 | 1.08064083 |
| 47 | TYRO3 | 1.07660054 |
| 48 | FGR | 1.06262948 |
| 49 | EPHA3 | 1.03339649 |
| 50 | MAP3K11 | 1.02623080 |
| 51 | FGFR3 | 1.01944816 |
| 52 | PIM2 | 1.00952822 |
| 53 | MAP3K1 | 1.00372349 |
| 54 | MARK2 | 0.99118425 |
| 55 | PRKCQ | 0.98939478 |
| 56 | MAPK12 | 0.98930092 |
| 57 | KIT | 0.98381235 |
| 58 | MOS | 0.97324835 |
| 59 | CLK1 | 0.96710642 |
| 60 | ALK | 0.86860096 |
| 61 | LYN | 0.85909392 |
| 62 | TEC | 0.85451416 |
| 63 | JAK2 | 0.81351021 |
| 64 | CDK9 | 0.81018486 |
| 65 | EEF2K | 0.80885975 |
| 66 | IRAK4 | 0.80562265 |
| 67 | SGK3 | 0.80406630 |
| 68 | DMPK | 0.80211339 |
| 69 | PRKD2 | 0.79477776 |
| 70 | NME1 | 0.78023181 |
| 71 | FRK | 0.75898911 |
| 72 | CDK4 | 0.75531519 |
| 73 | PRPF4B | 0.74773454 |
| 74 | CAMKK1 | 0.73033626 |
| 75 | CAMK1D | 0.72138963 |
| 76 | RAF1 | 0.69021613 |
| 77 | PDGFRB | 0.67716139 |
| 78 | FGFR4 | 0.67088051 |
| 79 | SMG1 | 0.66340043 |
| 80 | PDK1 | 0.64864750 |
| 81 | HIPK2 | 0.64266462 |
| 82 | CAMK1 | 0.63801072 |
| 83 | MAPKAPK5 | 0.63023961 |
| 84 | MAPK4 | 0.62252125 |
| 85 | MAPK11 | 0.60349729 |
| 86 | MAP3K3 | 0.59927971 |
| 87 | DAPK1 | 0.59451738 |
| 88 | CAMKK2 | 0.58992732 |
| 89 | BTK | 0.58375544 |
| 90 | ICK | 0.56916680 |
| 91 | FYN | 0.56600755 |
| 92 | TNK2 | 0.56421838 |
| 93 | TNIK | 0.56417751 |
| 94 | NLK | 0.56198732 |
| 95 | SGK2 | 0.55850475 |
| 96 | TRIB3 | 0.55387618 |
| 97 | NEK9 | 0.54880679 |
| 98 | EGFR | 0.52812984 |
| 99 | PRKD3 | 0.52772369 |
| 100 | PNCK | 0.52768479 |
| 101 | CDK5 | 0.52135785 |
| 102 | TRPM7 | 0.52113076 |
| 103 | MAP2K7 | 0.51857000 |
| 104 | MARK3 | 0.51689605 |
| 105 | ROCK2 | 0.51340118 |
| 106 | MAP3K4 | 0.50188114 |
| 107 | PKN1 | 0.50109978 |
| 108 | MAP3K5 | 0.49700893 |
| 109 | MAPKAPK3 | 0.48684040 |
| 110 | ACVR1B | 0.47835924 |
| 111 | PLK2 | 0.47121782 |
| 112 | MINK1 | 0.45581443 |
| 113 | MARK1 | 0.44072320 |
| 114 | MELK | 0.43959003 |
| 115 | PAK6 | 0.43556423 |
| 116 | RIPK1 | 0.43245531 |
| 117 | INSR | 0.43226433 |
| 118 | KSR2 | 0.43220824 |
| 119 | MAP2K6 | 0.43049240 |
| 120 | STK10 | 0.42693359 |
| 121 | BRD4 | 0.42336579 |
| 122 | SGK1 | 0.42134241 |
| 123 | PRKCG | 0.42099759 |
| 124 | SIK1 | 0.41877336 |
| 125 | IRAK1 | 0.40069241 |
| 126 | CSF1R | 0.39775296 |
| 127 | MAP2K3 | 0.39575593 |
| 128 | SGK494 | 0.39399805 |
| 129 | SGK223 | 0.39399805 |
| 130 | MAP3K10 | 0.38584189 |
| 131 | TSSK6 | 0.38421957 |
| 132 | MAPKAPK2 | 0.37353659 |
| 133 | CASK | 0.36806138 |
| 134 | MAPK3 | 0.35363407 |
| 135 | PTK2B | 0.34506386 |
| 136 | PRKAA2 | 0.34432797 |
| 137 | CAMK4 | 0.33939112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47947608 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.41457777 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32388990 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.24330206 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15087222 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.14334153 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.09259205 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07640242 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89078002 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.82107538 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77047147 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75253668 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.69004402 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63394576 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61689538 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60938723 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50845900 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50287751 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45237273 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.42951838 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.40301925 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36065919 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35375279 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29771031 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29510345 |
| 26 | Nicotine addiction_Homo sapiens_hsa05033 | 1.27316347 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25178491 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24581323 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.23791847 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23494087 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21492137 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21203932 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20017456 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.19837003 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19780184 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.16641059 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16519366 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16121404 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.15549678 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.15026925 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13938733 |
| 42 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.13788314 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13433890 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13217542 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11058793 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10393345 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09714797 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.06954698 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04853323 |
| 50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03936022 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02694589 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 1.00724344 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99798553 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.98867750 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98464367 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98457775 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94415484 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93711934 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93305740 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 0.91850932 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90187828 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.86957973 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86939896 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.86177089 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85805749 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82542986 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.81464706 |
| 68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81440702 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79979794 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79367881 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78821982 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78659726 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78181554 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.78065839 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77942647 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77691279 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77508437 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77010930 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76522778 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.76221118 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75130957 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74002313 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70078883 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70024649 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.69926430 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69060169 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69020881 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68895874 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67037465 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66608755 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65601170 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.65086713 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.64210158 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63667800 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62066039 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59814810 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58868635 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58460328 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.58324365 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.58293123 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57620226 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57012287 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56572134 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.56402387 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56130883 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56037175 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.52731057 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.51519992 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50783961 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49963797 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49255299 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48390373 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48273967 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48005113 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42964942 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42025808 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41594548 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40932601 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.38179417 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.32031172 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30036664 |

